Top Biotech Companies (3,705)
We are entering a new era of medicine, where cancer is treated with cellular therapies: living, smart, targeted drugs. While enormous strides have been made, especially in hematologic cancers, the full promise of these therapies still lies ahead. Cell-based immunotherapies have yet to show substantial benefit in solid tumors, which represent the vast majority of cancers. Our goal is nothing...
University Health Network is Canada's largest research hospital and a public research and teaching hospital network in Toronto, Ontario, known for its scope of research and complexity of cases.
Established in 1988, Hikal is a reliable partner to companies in the Pharmaceutical, Animal Health, Biotech, Crop Protection and Specialty Chemical industries. We manufacture and supply quality Active Ingredients, Intermediates, Biocides to the global life sciences industry. Hikal has five manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and Bengaluru (Jigani) and a world-class Research & Technology centre...
SHINE Medical Technologies, LLC is a nuclear technology company focused on developing and producing medical isotopes for diagnostic and therapeutic purposes using fusion technology. They also aim to generate carbon-free energy from nuclear fusion.
.png){kind=logo}
United BioSource LLC (UBC) is the leading provider of evidence development solutions with expertise in uniting evidence and access. UBC helps biopharma mitigate risk, address product hurdles, and demonstrate safety, efficacy, and value under real-world conditions. Underpinned by our scientific expertise, data and analytics, and innovative technologies, we offer our customers flexible solutions generating the relevant real-world data necessary to...
UBC's Top Stability & Growth Strengths
Strong Market Position & Advantage: UBC is repeatedly described as a leader in specialized biopharma service niches such as evidence development, REMS administration, and pharmacovigilance, supported by its scale (global footprint across multiple countries) and established operating history since the early 2000s.
Innovation-Driven Growth: The company highlights tech-enabled solutions and modernization efforts (e.g., HL7/FHIR interoperability work and pharmacovigilance reporting platform upgrades), signaling continued investment in capabilities that can support durable growth.
Strategic Partnerships: Multiple strategic partnerships and collaborations (e.g., with Datavant and Osmind) are cited as expanding offerings in observational research, REMS workflow integration, and patient access programs, indicating active ecosystem building.
Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. Advances in these areas have enabled us to decode the mysteries of genetic modifiers in a range of severe diseases, which we aim to turn into medicines that mimic protective mutations. We have assembled a world-class team that we need...
Maze Therapeutics's Top Stability & Growth Strengths
Investor Backing & Capital Strength: The company completed an upsized IPO, an oversubscribed private placement, and prior oversubscribed financing, with guidance that cash on hand funds operations into the second half of 2027. Active participation in investor conferences and supportive analyst sentiment further indicate strong access to capital.
Innovation-Driven Growth: The Compass platform integrates human genetics, functional genomics, and data science to create precision small‑molecule programs, with early human data (e.g., MZE782 proof‑of‑mechanism) and advancing studies (MZE829 Phase 2) reinforcing its productivity. The strategy of mimicking protective genetic modifiers has produced multiple clinical candidates in kidney and metabolic diseases.
Product Line Growth: Two wholly owned programs advanced in 2024–2025—MZE829 in Phase 2 for APOL1 kidney disease and MZE782 moving from Phase 1 toward Phase 2 in PKU and CKD—while a Pompe program (MZE001) was partnered. Planned Phase 2 initiations and upcoming readouts point to an expanding clinical footprint.
Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of...
Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders. Our lead asset is Pridopidine, a first-in-class oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children. Pridopidine is currently being evaluated for the treatment of Huntington’s disease in our global Phase 3 PROOF-HD trial,...
MaverickX is a chemical technology company that develops advanced chemistry and enzymatic solutions to modernize natural resource extraction. They focus on oil, gas, and mining sectors, providing products like PetroX and LithX to enhance recovery of oil and critical metals from existing infrastructure, aiming to improve economic value and sustainability in resource production.
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with...
Nirvesh Enterprises is a Hyderabad-based healthcare and biotechnology venture developing technology-enabled products, research collaborations, and translational innovations. It combines medicine, engineering, neuroscience, biomedical sciences, and entrepreneurship to address clinical needs through affordable, evidence-based solutions. The company also develops precision medical devices, brain-sensing and neurotechnology solutions, supports clinical research, and provides manufacturing, quality, and regulatory capabilities for practical healthcare implementation in...
Exai Bio is a next-generation liquid biopsy company. Our mission is to enable a world where cancer can be detected early, diagnosed accurately, treated in a personalized and targeted way, and ultimately cured. The company’s proprietary RNA and artificial intelligence-based liquid biopsy platform delivers clinical insights into cancer biology to enable the earliest, most accurate diagnosis of cancer. Exai Bio...
Putney develops high quality veterinary medicine, helping vets and pet owners to evaluate the best treatment options for their pet patients.
SINTX is a spinal and orthopedic implant company using its silicon nitride ceramic tech to develop spine and total joint implants.
Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that is driving the future of cellular immuno-oncology (IO).
CS Genetics is developing groundbreaking new technology for single cell genomics, based on foundational scientific insights and sophisticated innovations. Our technology will democratize the use of single cell and empower researchers to tackle bigger and better science! We've developed a disruptive platform for single-cell genomics which leverages instrument-free, solution-phase chemical biology to provide unmatched ease-of-use, scalability, and affordability.
Collaborative XR Software Platform for Molecular Design. Next step in computational/medicinal chemistry, structural biology, and beyond.
VirtualScopics provides imaging solutions for clinical trials in the pharmaceutical, biotechnology, and medical device industries.
Re-gen Active Lab is an Irving, Texas, based Biotechnology Company established in 2018 with a goal of revolutionizing regenerative medicine through the development of novel stem cell therapy for wound healing, regeneration, anti-inflammatory, and well-being applications. We collaborate with hospitals and universities around the globe to exploit the paramount potential of stem cells through research and development. All our products...
Recent winner of the Green Chemistry award, Vestaron is leading a peptide-based revolution in crop protection. We are committed to providing growers with novel, effective chemistries that address proven targets. Our peptides overcome existing resistance issues while offering a desired safety profile for workers, beneficials and the environment. Initially, Vestaron is focused on a class of peptides that kills insect pests...
